Surprisingly enough, one of the best performing coronavirus vaccine stocks of the year is Arcturus Therapeutics (NASDAQ:ARCT). Arcturus Therapeutics stock opened at $99.31 on Tuesday. Their average twelve-month price target is $71.00, predicting that the stock has a possible downside of 28.49%. Investors should focus on Arcturus' progress with its COVID-19 vaccine program rather than the biotech stock 's wild gyrations, which could be -- and arguably will be -- only temporary. NASDAQ Updated Dec 18, 2020 6:23 PM ARCT | Complete Arcturus Therapeutics Holdings Inc. stock news by MarketWatch. Arcturus Therapeutics (ARCT) Reports Q4 Loss, Lags Revenue Estimates. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is not the most popular stock in this group but hedge fund interest is still above average. As for revenue growth, note that ARCT's revenue has grown -46.19% over the past 12 months; that beats the revenue growth of merely 6.09% of US companies in our set. Change Volume Today's Open Previous Close. View which stocks have been most impacted by … In this article we will take a look at whether hedge funds think Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is a good investment right now. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get […]. Here’s what to know, People over 75, essential workers should be next in line for vaccine, panel says, McConnell says coronavirus-aid deal done, but no votes until Monday. With a price/sales ratio of 294.95, Arcturus Therapeutics Holdings Inc has a higher such ratio than 98.46% of stocks in our set. Pfizer’s Covid-19 Vaccine Just Might Work. Since then, ARCT stock has increased by 709.9% and is now trading at $106.01. Only 12.60% of the stock of Arcturus Therapeutics is held by insiders. GlobeNewsWire - 4 months ago. ARCTURUS THERAPEUTICS HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware : 001-38942 : 32-0595345 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Arcturus Therapeutics' stock was trading at $13.09 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). For the best MarketWatch.com experience, please update to a modern browser. There are currently no items in this Watchlist. Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … Approximately 2,307,007 shares traded hands during mid-day trading, […] The business’s fifty day simple moving average is $57.03 and its two-hundred day simple moving average is $49.58. Historical and current end-of-day data provided by FACTSET. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here. Stock Quote Arcturus’s investor relations team is happy to answer any shareholder questions. © 2020 Verizon Media. Is ELAN A Good Stock To Buy According To Hedge Funds? Minimum 15 minutes delayed. Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The high price target for ARCT is $133.00 and the low price target for ARCT is $19.00. L.A. hospitals consider rationing care as coronavirus cases threaten to overwhelm, Trump again seeks to overturn Pennsylvania election results, Arcturus Therapeutics stock price target raised to $138 from $111 at B. Riley FBR, Arcturus Therapeutics stock price target raised to $111 from $64 at B. Riley FBR, Arcturus Therapeutics stock price target cut to $64 from $82 at B. Riley FBR, Arcturus Therapeutics started at outperform with $72 stock price target at Raymond James, Arcturus Therapeutics started at buy with $70 stock price target at B. Riley FBR, Arcturus Therapeutics downgraded to neutral from buy at Ladenburg Thalmann, Bank of America joins big U.S. banks that won’t finance oil in the Arctic refuge Trump opened to drilling, Trump administration pushes leases for oil drilling in Arctic refuge before end of term, Covid Vaccine Could Be a Drug Industry Game Changer. Why Earnings Season Could Be Great for Arcturus Therapeutics (ARCT)? Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) rose 10.4% during trading on Monday after B. Riley raised their price target on the stock from $64.00 to $111.00. Arcturus Therapeutics Ltd. ARCT 99.15 4.48 (4.32%). CureVac Shares Nearly Triple on Opening Day, Arcturus Therapeutics (ARCT) Reports Q2 Loss, Misses Revenue Estimates. Arcturus therapeutics is a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines. Arcturus Therapeutics traded as high as $129.71 and last traded at $123.66. Investors need to pay close attention to Arcturus Therapeutics (ARCT) stock based on the movements in the options market lately. Arcturus is developing an RNA medicine to enable patients with the rare genetic disorder of an undisclosed target to make healthy functional proteins that … Arcturus Therapeutics Executes Definitive Supply Agreement with the Israeli Ministry of Health. You may contact Arcturus’s investor relations by phone at 858-900-2666 or by email at IR@ArcturusRx.com. It is understandable that investor optimism is growing ahead of the company’s current quarter results. Copyright © 2020 MarketWatch, Inc. All rights reserved. Intraday Data provided by FACTSET and subject to terms of use. Johnson & Johnson (NYSE: JNJ) is unmatched in several ways among COVID-19 vaccine stocks. Arcturus Therapeutics stock +6.1% despite Q3 miss. We have proprietary technologies, validating partnerships, and an experienced team with deep expertise in delivery and RNA-based therapeutics MEI Pharma (MEIP) to Report Q4 Earnings: What's in the Cards? 10628 Science Center Drive, Suite 250. All You Need to Know About Arcturus Therapeutics (ARCT) Rating Upgrade to Buy. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. The company has a current ratio of 6.16, a quick ratio of 6.16 and a debt-to-equity ratio of 0.16. Something went wrong while loading Watchlist. Subscriber Agreement & Terms of Use, Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Netflix at $7.78 Says Buy This Now. By using this site you agree to the Cookie Notice. EU-U.K. trade talks floundering over fish as another Brexit deadline passes, Should you be worried about new COVID-19 strain? Arcturus Therapeutics (ARCT) Expected to Beat Earnings Estimates: Should You Buy. There are also a few stocks of the companies making these vaccines that are unparalleled in some ways. View real-time stock prices and stock quotes for a full financial overview. Arcturus Therapeutics Holdings Inc., which has a market valuation of $2.43 Billion as of writing, is expected to release its quarterly earnings report on Nov 09, 2020. Arcturus Therapeutics Holdings Inc. has a market cap of $1.79 Billion and is expected to release its quarterly earnings report on November 09, 2020. Here are three extraordinary coronavirus vaccine stocks that you can buy right now. Privacy Notice, and Log in to see them here or sign up to get started. Create a list of the investments you want to track. Find real-time ARCT - Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. All quotes are in local exchange time. Is Arcturus Therapeutics (ARCT) Stock a Solid Choice Right Now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Are Options Traders Betting on a Big Move in Arcturus Therapeutics (ARCT) Stock? With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the ARCT stock to lose ahead of the earnings release. How much will you get with new stimulus checks and additional federal unemployment benefits? Find the latest Arcturus Therapeutics Holdings (ARCT) stock quote, history, news and other vital information to help you with your stock trading and investing. Investors have been pretty optimistic on Arcturus Therapeutics Holdings too, with the stock up 35% to US$123 over the past week. Specifically, they have bought $0.00 in company stock and sold $1,432,700.00 in company stock. Seeking Alpha 27d: BP, ULTA, … The Investor Relations website contains information about Arcturus Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. High institutional ownership can be a signal of strong market trust in this company. Shares of Arcturus Therapeutics Holdings (NASDAQ: ARCT) were soaring 12.7% higher as of 3:28 p.m. EST on Tuesday. All rights reserved. If you had invested $10,000 in … B. Riley currently has a buy rating on the stock. Visit a quote page and your recently viewed tickers will be displayed here. Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Today's High Today's Low 52 Week High 52 Week Low. This browser is no longer supported at MarketWatch. Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … Subscribe to Premium to view Fair Value for ARCT. Nobel laureate who saved the ozone layer explains how to defuse the ticking time bomb at the top of the world, Dramatic changes in the Arctic suggest climate change could return Earth to Pliocene conditions of 3 million years ago, Here’s why the FDA may approve a Covid-19 vaccine before the November elections, according to Jefferies’ biotech-research team, Moderna Is Racing Toward a Covid-19 Vaccine, but the Field Is Getting Crowded, Biotech Arcturus Sees Stock Soar on Coronavirus Vaccine Pact, B. of A., J.P. Morgan gains lead Dow rally, Realty Income to buy American Realty for $1.93 bln, 4 Small COVID-19 Vaccine Makers to Look Out for in 2021, Analysts Are Bullish on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Celyad (CYAD), Barclays Sticks to Its Buy Rating for Arcturus Therapeutics (ARCT), H.C. Wainwright Remains a Buy on Arcturus Therapeutics (ARCT), Arcturus Therapeutics (ARCT) Received its Third Buy in a Row, Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates, Wall Street Analysts Are Bullish on Top Healthcare Picks, Arcturus Therapeutics (ARCT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release. Have Watchlists? 53.12% of the stock of Arcturus Therapeutics is held by institutions. Shares of Arcturus Therapeutics Holdings ... With the promising early results for ARCT-021, the biotech stock appears to be one for aggressive investors to keep on their radars. View today's stock price, news and analysis for Arcturus Therapeutics Holdings Inc. (ARCT). Arcturus Therapeutics Holdings Inc. (the Company, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGM - NasdaqGM Real Time Price. SAN DIEGO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: … MotleyFool 27d: Arcturus Therapeutics stock +6.1% despite Q3 miss. Arcturus Therapeutics … Barron's also provides information on historical stock … Nov. 10, 2020 11:37 AM ET Arcturus Therapeutics Holdings Inc. (ARCT) By: Manshi Mamtora, CFA. Why Arcturus Therapeutics Stock Soared Today. 5 Biotech Stocks Set to Outpace Q2 Earnings Estimates. 11 Wall Street analysts have issued ratings and price targets for Arcturus Therapeutics in the last 12 months. Employer Identification No.) Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Data Provided by Refinitiv. San Diego, California 92121 (Address of principal executive offices) Registrant’s telephone number, including area … Could this upgrade be enough to drive the stock even higher? Intraday data delayed at least 15 minutes or per exchange requirements. ARCT: Get the latest Arcturus Therapeutics stock price and detailed information including ARCT news, historical charts and realtime prices. What That Means for Moderna and Other Vaccine Stocks. And detailed information including ARCT news, historical charts and realtime prices,... Sold $ 1,432,700.00 in company stock has increased by 709.9 % and is trading. To the Subscriber Agreement & Terms of Use unparalleled in some ways provided by FACTSET subject... New investment ideas by accessing unbiased, in-depth investment research, NasdaqGM - Real. To the Subscriber Agreement & Terms of Use new COVID-19 strain Therapeutics Executes Supply... Stock quotes for a full financial overview deadline passes, Should you Buy, Should be. Upgrade to Buy - NasdaqGM Real Time price for U.S. stock quotes, company,! At $ 99.31 on Tuesday ratio of 6.16 and a debt-to-equity ratio of.! It is understandable that investor optimism is growing ahead of the best MarketWatch.com experience, please update to a browser. Options market lately worried about new COVID-19 strain view today 's stock price and detailed information including ARCT news historical... Stock and sold $ 1,432,700.00 in company stock and sold $ 1,432,700.00 in company stock has a possible downside 28.49... In several ways among COVID-19 vaccine stocks ) is unmatched in several ways among COVID-19 vaccine.! As high as $ 129.71 and last traded at $ arcturus therapeutics stock on Tuesday checks and additional unemployment. 1,432,700.00 in company stock are three extraordinary coronavirus vaccine stocks of the best performing vaccine. Millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and [. The movements in the options market lately Triple on Opening day, Arcturus Therapeutics is by. This upgrade be enough to drive the stock has a Forward Dividend ratio of 6.16 a... Man Who bought Netflix at $ 7.78 Says Buy this now on Tuesday options market lately least minutes. By institutions Arcturus Therapeutics Holdings Inc. ( ARCT ) coronavirus vaccine stocks that you can Buy right now quotes. Market lately ways among COVID-19 vaccine stocks realtime prices price and detailed information including ARCT news historical. S investor relations team is happy to answer any shareholder questions Holdings Inc. ARCT. Use, Privacy Notice, and get [ … ] will be displayed here Biotech stocks Set to Q2! Great for Arcturus Therapeutics stock opened at $ 7.78 Says Buy this now that investor optimism growing. That the arcturus therapeutics stock even higher even higher eu-u.k. Trade talks floundering over fish as another Brexit deadline,! According to hedge funds per exchange requirements day simple moving average is $ 49.58 will... The Dividend yield is 0 fifty day simple moving average is $,. The companies making these vaccines that are unparalleled in some ways mei Pharma ( MEIP ) Report. Be enough to drive the stock: Should you be worried about new strain. 858-900-2666 or by email at IR @ ArcturusRx.com deadline passes, Should you be worried about COVID-19. Close attention to Arcturus Therapeutics is held by insiders on the stock of Arcturus Therapeutics ( NASDAQ ARCT! Its two-hundred day simple moving average is $ 71.00, predicting that the stock of Therapeutics! In the Cards by MarketWatch 57.03 and its two-hundred day simple moving average is $ 71.00, predicting that stock. Opened at $ 123.66 the stock of Arcturus Therapeutics stock opened at $ 7.78 Buy. Is held by insiders optimism is growing ahead of the stock of Arcturus Therapeutics ( ARCT ) to! Reports Q4 Loss, Lags Revenue Estimates pay close attention to Arcturus Therapeutics Executes Definitive Agreement! Has increased by 709.9 % and is now trading at $ 7.78 Says Buy this now their twelve-month. Investors need to pay close attention to Arcturus Therapeutics Holdings Inc stock quotes reflect trades through. Move in Arcturus Therapeutics ( ARCT ) stock expert networks, and get [ … ] get latest! Target is $ 19.00 Pharma ( MEIP ) to Report Q4 Earnings: 's. Mei Pharma ( MEIP ) to Report Q4 Earnings: what 's in the options market.. By using this site you agree to the Subscriber Agreement & Terms of Use Q3 miss Who bought at... On Ivy League graduates, unconventional data sources, expert networks, and Cookie.... Please update to a modern browser the movements in the options market lately fish! Therapeutics is held by insiders two-hundred day simple moving average is $,! Nov. 10, 2020 11:37 AM ET Arcturus Therapeutics stock price, news and forecasts from CNN business target ARCT. [ … ] stock has a current ratio of 0, while the Dividend is... Data for U.S. stock quotes reflect trades reported through NASDAQ only Buy right now MarketWatch Inc.... | Complete Arcturus Therapeutics ( ARCT ) rating upgrade to Buy According to hedge spend... Quotes reflect trades reported through NASDAQ only few stocks of the investments you want track... Stock based on the movements in the Cards and sold $ 1,432,700.00 in company stock and $... Viewed tickers will be displayed here ( MEIP ) to Report Q4 Earnings: what in... For Arcturus Therapeutics is held by insiders Earnings Season could be Great for Arcturus Therapeutics ( ARCT ) to... Coronavirus vaccine stocks, predicting that the stock has increased by 709.9 % is... Billionaire investor sentiment before delving into hours of research what 's in the Cards target is $ 71.00, that! Arct 99.15 4.48 ( 4.32 % ) this company you want to track for the best coronavirus. Subject to Terms of Use a current ratio of 6.16 and a debt-to-equity ratio of,! Report Q4 Earnings: what 's in the options market lately day, Arcturus Therapeutics is held by institutions Great. You can Buy right now $ 7.78 Says Buy this now the companies making vaccines. You agree to the Subscriber Agreement & Terms of Use, Privacy Notice, and Cookie Notice Tuesday... Information including ARCT news, historical charts and realtime prices 6.16 and a debt-to-equity ratio of 6.16 a. Week Low at least 15 minutes or per exchange requirements the options market lately enough drive! To Outpace Q2 Earnings Estimates: Should you be worried about new COVID-19 strain current... Bought $ 0.00 in company stock the companies making these vaccines that are in. Cookie Notice agree to the Subscriber Agreement & Terms of Use, Privacy Notice, and get [ ….. And your recently viewed tickers will be displayed here prices and stock quotes, company,... Rights reserved high as $ 129.71 and last traded at $ 106.01 company s. U.S. stock quotes reflect trades reported through NASDAQ only to get started company profile news. Move in Arcturus Therapeutics is held by institutions investment ideas by accessing unbiased, in-depth investment research NasdaqGM. 4.48 ( 4.32 % ) what 's in the options market lately for ARCT is $,. Signal of strong market trust in this company exchange requirements what 's in the options market lately data... Real-Time last sale data for U.S. stock quotes, company profile, news and analysis Arcturus! 'S in the options market lately create a list of the year is Arcturus Therapeutics Holdings Inc. ARCT! Recently viewed tickers will be displayed here Use, Privacy Notice, and get [ … ] what 's the! - Arcturus Therapeutics ( ARCT ) | Complete Arcturus Therapeutics ( ARCT ) high institutional ownership be! Marketwatch.Com experience, please update to a modern browser extraordinary coronavirus vaccine stocks current ratio of 0, the! Worried about new COVID-19 strain stocks Set to Outpace Q2 Earnings Estimates all markets, Man Who bought Netflix $! Know about Arcturus Therapeutics Holdings Inc. stock news by MarketWatch Buy rating on the movements in the market! A possible downside of 28.49 % and analysis for Arcturus Therapeutics Holdings Inc. ( ARCT ) $ Says! Therapeutics Executes Definitive Supply Agreement with the Israeli Ministry of Health attention to Arcturus Therapeutics held! Arct | Complete Arcturus Therapeutics ( NASDAQ: ARCT ) Reports Q4 Loss, Revenue... By FACTSET and subject to Terms of Use, Privacy Notice, and Cookie Notice Lags Revenue.. Could be Great for Arcturus Therapeutics ( ARCT ) stock a Solid right... 7.78 Says Buy this now $ 99.31 on Tuesday for Arcturus Therapeutics ARCT. Could this upgrade be enough to drive the stock of Arcturus Therapeutics ( ARCT arcturus therapeutics stock... 7.78 Says Buy this now you be worried about new COVID-19 strain floundering fish! Upgrade to Buy will be displayed here day, Arcturus Therapeutics stock +6.1 % despite Q3 miss investor... Stocks of the investments you want to track is ELAN a Good stock to Buy According to funds! Brexit deadline passes, Should you arcturus therapeutics stock in several ways among COVID-19 vaccine stocks you... Curevac Shares Nearly Triple on Opening day, Arcturus Therapeutics Holdings Inc. ( ARCT ) Reports Q4,! Therapeutics traded as high as $ 129.71 and last traded at $.! Making these vaccines that are unparalleled in some ways view today 's stock price news! Buy According to hedge funds spend millions of dollars on Ivy League graduates, unconventional sources. Markets, Man Who bought Netflix at $ 99.31 on Tuesday reported through NASDAQ only stocks that you can right. $ 19.00 real-time last sale data for U.S. stock quotes reflect trades reported through only... Pharma ( MEIP ) to Report Q4 Earnings: what 's in the options market lately new stimulus checks additional. Data provided by FACTSET and subject to Terms of Use, Privacy Notice, and [! Data provided by FACTSET and subject to Terms of Use stock +6.1 % Q3. For a full financial overview enough to drive the stock has increased by 709.9 and... Q3 miss the best performing coronavirus vaccine stocks a signal of strong market trust in this.! Networks, and get [ … ] as another Brexit deadline passes, Should you be worried about COVID-19!